These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23426452)

  • 21. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial.
    Broeders JA; Rijnhart-de Jong HG; Draaisma WA; Bredenoord AJ; Smout AJ; Gooszen HG
    Ann Surg; 2009 Nov; 250(5):698-706. PubMed ID: 19801931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic esophagitis is more severe in gastroesophageal reflux patients with a positive family history.
    Tsibouris P; Moussia M; Kalantzis C; Apostolopoulos P; Alexandrakis G; Lapas C; Kalantzis N
    J Clin Gastroenterol; 2012 Mar; 46(3):201-8. PubMed ID: 22138842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
    Noar MD; Lotfi-Emran S
    Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
    Kunsch S; Neesse A; Linhart T; Steinkamp M; Fensterer H; Adler G; Gress TM; Ellenrieder V
    Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients.
    Bai Y; Du Y; Zou D; Jin Z; Zhan X; Li ZS; Yang Y; Liu Y; Zhang S; Qian J; Zhou L; Hao J; Chen D; Fang D; Fan D; Yu X; Sha W; Nie Y; Zhang X; Xu H; Lv N; Jiang B; Zou X; Fang J; Fan J; Li Y; Chen W; Wang B; Zou Y; Li Y; Sun M; Chen Q; Chen M; Zhao X;
    J Gastroenterol Hepatol; 2013 Apr; 28(4):626-31. PubMed ID: 23301662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice.
    Horowitz N; Moshkowitz M; Leshno M; Ribak J; Birkenfeld S; Kenet G; Halpern Z
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1277-83. PubMed ID: 17944742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma.
    Kent MS; Luketich JD; Irshad K; Awais O; Alvelo-Rivera M; Churilla P; Fernando HC; Landreneau RJ
    Ann Thorac Surg; 2007 Nov; 84(5):1710-5; discussion 1715-6. PubMed ID: 17954091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studies.
    Ponce J; Garrigues V; Agréus L; Tabaglio E; Gschwantler M; Guallar E; Tafalla M; Nuevo J; Hatlebakk J
    Int J Clin Pract; 2012 Sep; 66(9):897-905. PubMed ID: 22805293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
    Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study.
    Eherer AJ; Netolitzky F; Högenauer C; Puschnig G; Hinterleitner TA; Scheidl S; Kraxner W; Krejs GJ; Hoffmann KM
    Am J Gastroenterol; 2012 Mar; 107(3):372-8. PubMed ID: 22146488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
    Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
    Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
    Digestion; 2007; 75 Suppl 1():62-8. PubMed ID: 17489034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2007; 75 Suppl 1():69-78. PubMed ID: 17489035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.
    Dossett ML; Mu L; Davis RB; Bell IR; Lembo AJ; Kaptchuk TJ; Yeh GY
    PLoS One; 2015; 10(9):e0136855. PubMed ID: 26422466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.